| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| EPIC Bpifrance | Member of 10% owner group | 6-8, BOULEVARD HAUSSMANN, PARIS, FRANCE | /s/ Sophie Paquin, Director of Legal Affairs EPIC Bpifrance | 19 Dec 2025 | 0001731121 |
| Bpifrance Participations SA | Member of 10% owner group | 6-8, BOULEVARD HAUSSMANN, PARIS, FRANCE | /s/ Sophie Paquin, Director of Legal Affairs Bpifrance Participations | 19 Dec 2025 | 0001581835 |
| Bpifrance SA | Member of 10% owner group | 6-8, BOULEVARD HAUSSMANN, PARIS, FRANCE | /s/ Sophie Paquin, Director of Legal Affairs, Bpifrance Investissement S.A.S. | 19 Dec 2025 | 0001731118 |
| Bpifrance Investissement S.A.S. | Member of 10% owner group | 6-8, BOULEVARD HAUSSMANN, PARIS, FRANCE | /s/ Laurence Giraudon, Chief Operating Officer Finance and Operations Department, Asset Management Division, Caisse des Depots | 19 Dec 2025 | 0002065260 |
| CAISSE DES DEPOTS ET CONSIGNATIONS | Member of 10% owner group | C/O 56, RUE DE LILLE, PARIS, FRANCE | /s/ Boubakar Dione, Group Director of Legal Affairs, Bpifrance S.A. | 19 Dec 2025 | 0001056947 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DBVT | Ordinary Shares | Sale | $9,859,032 | -2,036,990 | -19% | $4.84 | 8,635,472 | 17 Dec 2025 | By Bpifrance Participations S.A. | F1, F2 |
| transaction | DBVT | Ordinary Shares | Sale | $211,200 | -40,000 | -0.46% | $5.28 | 8,595,472 | 17 Dec 2025 | By Bpifrance Participations S.A. | F2, F3 |
| transaction | DBVT | Ordinary Shares | Sale | $5,413,912 | -1,292,103 | -15% | $4.19 | 7,303,369 | 18 Dec 2025 | By Bpifrance Participations S.A. | F2, F4 |
| holding | DBVT | Ordinary Shares | 226,133 | 17 Dec 2025 | By Innobio FPCI | F5 |
Bpifrance Epic is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1741 to EURO 1.00 as of December 17, 2025. The shares were sold in multiple transactions at prices ranging from $4.24 to $5.23 per share, inclusive. The reporting person unterakes to provide DBV Technologies S.A., any security holder of DBV Technologies S.A., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 1 and 4 of this Form 4. |
| F2 | Bpifrance Participations S.A. ("Bpifrance Participations") directly owns the reported shares. Bpifrance Participations is a subsidiary owned at 99.99% by Bpifrance S.A. ("Bpifrance"). Bpifrance is jointly owned by Caisse des Depots et Consignations ("CDC") at 49.2% and EPIC Bpifrance ("EPIC") at 49.2%. CDC and EPIC jointly control Bpifrance. |
| F3 | The price reported in Column 4 reflects the conversion of EURO to USD at an exchange rate of $1.1741 to EURO 1.00 as of December 17, 2025. |
| F4 | The price reported in Column 4 is a weighted average price in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1727 to EURO 1.00 as of December 18, 2025 . The shares were sold in multiple transactions at prices ranging from $3.79 to $4.32 per share, inclusive. |
| F5 | Innobio FPCI ("Innobio") directly owns the reported shares. Innobio is a fund managed by Bpifrance Investissement S.A.S. ("Bpifrance Investissement"), a subsidiary owned at 100% by Bpifrance Participations. |